These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 1037216

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. General and cerebral haemodynamic activity of ethyl apovincaminate.
    Kárpáti E, Szporny L.
    Arzneimittelforschung; 1976; 26(10a):1908-12. PubMed ID: 1037212
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of ethyl apovincaminate on vasospasm of the circulatory isolated internal carotid artery in dogs.
    Mchedlishvili GI, Ormotsadze LG.
    Arzneimittelforschung; 1981; 31(3):414-8. PubMed ID: 7194665
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Protective activity of ethyl apovincaminate on ischaemic anoxia of the brain.
    Biró K, Kárpáti E, Szporny L.
    Arzneimittelforschung; 1976; 26(10a):1918-20. PubMed ID: 1037215
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Radiocirculographic study of the effect of ethyl apovincaminate on the cerebral circulation.
    Fényes S, Földes J.
    Arzneimittelforschung; 1976; 26(10a):1963-4. PubMed ID: 798589
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of ethyl apovincaminate on the central nervous system.
    Pálosi E, Szporny L.
    Arzneimittelforschung; 1976; 26(10a):1926-9. PubMed ID: 1037217
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative study of the effect of ethyl apovincaminate and xantinol nicotinate in cerebrovascular diseases. Immediate drug effects on the concentrations of carbohydrate metabolites and electrolytes in blood and CSF.
    Vámosi B, Molnár L, Demeter J, Túry F.
    Arzneimittelforschung; 1976; 26(10a):1980-4. PubMed ID: 1037229
    [Abstract] [Full Text] [Related]

  • 17. Biochemical effects of ethyl apovincaminate.
    Rosdy B, Balázs M, Szporny L.
    Arzneimittelforschung; 1976; 26(10a):1923-6. PubMed ID: 191039
    [Abstract] [Full Text] [Related]

  • 18. The renin-angiotensin system and the effect of propranolol upon the cerebral cortical and hypothalamic circulation in hypoxia.
    Olteanu A, Grosu L, Vlasie N, Pavel T, Barabas E, Baciu I.
    Rom J Physiol; 1997; 34(1-4):25-33. PubMed ID: 9653807
    [Abstract] [Full Text] [Related]

  • 19. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM, Shkrobot SI, Borak VT.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409
    [Abstract] [Full Text] [Related]

  • 20. Vasodilating effect of ethyl apovincaminate on conjunctival vessels and simultaneous observation of parameters indicating adverse effect.
    Brooser G, Anda L, Domán J.
    Arzneimittelforschung; 1976; 26(10a):1975-7. PubMed ID: 1037227
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.